Mankind Pharma Ltd (MANKIND) — Cash Flow-to-Debt Ratio
Mankind Pharma Ltd (MANKIND) has a Cash Flow-to-Debt Ratio of 0.12x as of September 2025, meaning its operating cash flow of Rs16.37 Billion could theoretically repay 0% of its total liabilities (Rs132.85 Billion) in one year. See MANKIND FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mankind Pharma Ltd Cash Flow-to-Debt Ratio (2019–2026)
Historical debt coverage capacity for Mankind Pharma Ltd across 8 annual periods. For the full cash flow conversion analysis, see MANKIND cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Mankind Pharma Ltd (2019–2026)
Year-by-year debt coverage analysis for Mankind Pharma Ltd. Check Mankind Pharma Ltd (MANKIND) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.22x | Rs25.16 Billion | Rs115.18 Billion | ▲ +19.4% |
| 2025 | 0.18x | Rs24.13 Billion | Rs131.91 Billion | ▼ -79.7% |
| 2024 | 0.90x | Rs21.52 Billion | Rs23.87 Billion | ▲ +2.8% |
| 2023 | 0.88x | Rs18.13 Billion | Rs20.67 Billion | ▲ +170.1% |
| 2022 | 0.32x | Rs9.20 Billion | Rs28.31 Billion | ▼ -56.9% |
| 2021 | 0.75x | Rs11.37 Billion | Rs15.10 Billion | ▼ -1.3% |
| 2020 | 0.76x | Rs10.70 Billion | Rs14.02 Billion | ▲ +43.7% |
| 2019 | 0.53x | Rs6.00 Billion | Rs11.31 Billion | — |